Walmart Reports Q3 U.S. Total Comp +2.9% YoY; Reflects ~125bps Headwind From Pharmacy Deflation And Brand-To-Generic Transfers Related To Maximum Fair Price Regulation; Partially Offset By ~60bps Growth Primarily From GLP-1
FY27 comps reflect ~60bps Tailwind from GLP-1 vs ~100bps in FY25 and FY26 as script growth was more than offset by price-mix

